Impact of Benign Prostatic Hyperplasia Medications on Post Void Residual Volume: A Retrospective Study
Abstract
Introduction: A Benign Obstructive Uropathy (BPH) is a commonly observed cause of Bladder Outlet Obstruction (BOO) among old males. A clinical concern associated with this condition in the form of associated complications such as recurrent urinary tract infection, acute urinary retention and post renal failure.
The Post Void Residual volume (PVR) is considered as a good prognostic tool in ways of diagnosis and follow up the patients with BPH. Hence, this retrospective cross-sectional study aims to evaluate the efficacy of various BPH medications in the reduction of PVR. Accordingly, data were gathered from medical records of patients treated in Salmaniya Medical Complex in the Kingdom of Bahrain over two years. The result offers an insight into the value of various medical therapy in treatment of high PVR.
Methodology: In this study we collected data retrospectively from urology clinics from August 2022 to August 2024. The study included men aged 40 years old and older who were diagnosed with bladder outlet obstruction secondary to BPH at Salmaniya Medical Complex in the Kingdom of Bahrain. BPH was confirmed through combination of clinical symptoms as well as utilizing the International Prostate Symptom Score (IPSS) along with radiological assessment via trans-abdominal ultrasound demonstrating an enlarged prostate volume more than 25 ml. However, the study excluded patients who had incomplete medical records, previous surgical interventions, and presence of concomitant…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 220 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.